3 | SEC Filings Hub

Filing metadata

Accession number: 0001193125-26-006805
Form type: Form 3
Filer: 4D Molecular Therapeutics, Inc.
CIK: CIK 1650648
Filed: Jan 07, 2026
Reporting period: Jan 05, 2026
Description: Initial ownership

Documents

0001193125-26-006805-index.htm

Complete submission

0001193125-26-006805.txt

directory listing

Filed by

4D Molecular Therapeutics, Inc.